Evotec sees dynamic growth

Published: 28-May-2001


Evotec Biosystems continued its strong growth and the consolidation with Oxford Asymmetry International during the fourth quarter of 2000, pushed sales up 189% to e28.3 million (US$32 million). Before consolidation with OAI, Evotec's sales after nine months amounted to e9.8m (US$11.1 million), a 106% increase over the same period in 1999.

You may also like